In Parkinson’s disease (PD), the neuroprotective effects of smoking have been well established, attributed to mechanisms such as reduced immune activation and the alpha-synuclein interactions mediated by HLA-DRB1, where individuals lacking protective HLA-DRB1 AA alleles exhibit a reduced PD risk [14]. This evidence concerns the gene SNCA and Parkinson disease.